Specialty apparel retailer Gap Inc. (NYSE: GPS) reported lower earnings and revenues for the third quarter of 2019, owing mainly to a decline in comparable-store sales. The results, however, topped the Street view, sending the company’s stock higher during Thursday’s aftermarket trading session.
Total comparable store sales decreased by 4% annually. Old Navy Global, which accounts for about 50% of total sales, registered a 4% decline in comp-sales. Sales at Gap Global and Banana Republic dropped 7% and 3%, respectively. At $4 billion, third-quarter net sales were down 2% year-over-year, mainly due to unfavorable foreign exchange rates. However, the top-line surpassed analysts’ prediction.
Earnings Beat
Adjusted earnings came in at $0.53 per share during the three-month period, down from the year-ago level. Net income was $140 million or $0.37 per share, down from $266 million or $0.69 per share in the same period of last year. Analysts were looking for a faster decline.
Capital Return
At the end of October, merchandise inventory stood at $2.72 billion, up 2% year-over-year. During the quarter, Gap repurchased 2.9 million shares for $50 million and paid a dividend of $0.2425 per share.
“We are not pleased with the third-quarter results and are focused on aggressively addressing the operational issues that are hindering the performance of our brands. We continue to make progress against our separation plans, which will provide improved focus and a further catalyst for transformation,” said interim CEO Robert Fisher.
Outlook
For the full fiscal year, the management continues to expect unadjusted earnings to be in the range of $1.38 per share to $1.47 per share and adjusted earnings between $1.70 per share and $1.75 per share. Full-year comparable store sale is expected to be down mid-single digits, while net sales are forecast to be down low-single digits.
Also see: The Gap Q2 2019 Earnings Conference Call Transcript
Shares of Gap dropped 39% in 2019, losing steadily since the beginning of the year. Analysts’ consensus rating on the stock is hold, with an average price target of $17.53. The stock gained about 4% Thursday evening following the earnings report.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on